Publication:
Stereotactic ablative radiotherapy (SABR) in operable early stage non-small cell lung cancer (NSCLC) patients: challenge to claim being undisputed gold standard

Simple item page
dc.contributor.coauthorYalman, Deniz
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorSelek, Uğur
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T23:36:42Z
dc.date.issued2015
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue11
dc.description.openaccessNO
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume3
dc.identifier.doi10.3978/j.issn.2305-5839.2015.06.23
dc.identifier.eissn2305-5847
dc.identifier.issn2305-5839
dc.identifier.quartileQ3
dc.identifier.scopus2-s2.0-85015483458
dc.identifier.urihttps://doi.org/10.3978/j.issn.2305-5839.2015.06.23
dc.identifier.urihttps://hdl.handle.net/20.500.14288/12692
dc.identifier.wos218801500003
dc.language.isoeng
dc.publisherAme Publ Co
dc.relation.ispartofAnnals of Translational Medicine
dc.subjectOncology
dc.subjectMedicine
dc.subjectMedicine, Experimental
dc.titleStereotactic ablative radiotherapy (SABR) in operable early stage non-small cell lung cancer (NSCLC) patients: challenge to claim being undisputed gold standard
dc.typeOther
dc.type.otherEditorial material
dspace.entity.typePublication
local.contributor.kuauthorSelek, Uğur
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files

Collections

Publications without Fulltext